Morning Briefing
Summaries of health policy coverage from major news organizations
Donors Must Continue Funding R&D To Bring New Global Health Technologies To Patients
In this post in the Hill's "Congress Blog," Kaitlin Christenson, the coalition director of the Global Health Technologies Coalition; Jim Connolly, president and CEO of Aeras; and Mel Spigelman, president and CEO of the TB Alliance, respond to a recently released G-FINDER report that shows "overall global investment in the research and development (R&D) of [new global health technologies] has declined for the first time since 2007, when the tracking of such funding began," writing, "This decline is especially troubling given that there are more than 100 products in [the Product Development Partnerships' (PDPs)] pipelines."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
